A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia

Clinical trial NCT00083473 · TERMINATED

Trial details

NCT number: NCT00083473
Sponsor: Titan Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic Lymphoma, Small Lymphocytic

Start date: 2004-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.